Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.
Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. Lee AW, et al. Among authors: choi hc. Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580. doi: 10.1016/j.ijrobp.2019.06.2540. Epub 2019 Jul 2. Int J Radiat Oncol Biol Phys. 2019. PMID: 31276776
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK, Chan SY, Choi HC, Tong CC, Lam KO, Kwong DL, Vardhanabhuti V, Leung TW, Luk MY, Lee AW, Lee VH. Chan SK, et al. Among authors: choi hc. Front Oncol. 2020 Aug 21;10:1417. doi: 10.3389/fonc.2020.01417. eCollection 2020. Front Oncol. 2020. PMID: 32974150 Free PMC article.
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Chan SK, Chan SY, Tong CC, Lam KO, Kwong DL, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: choi hc. Oral Oncol. 2021 Mar;114:105158. doi: 10.1016/j.oraloncology.2020.105158. Epub 2021 Jan 25. Oral Oncol. 2021. PMID: 33508707
Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
Chan SK, Chau SC, Chan SY, Tong CC, Lam KO, Lai-Wan Kwong D, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: choi hc. Cancer Control. 2021 Jan-Dec;28:10732748211047117. doi: 10.1177/10732748211047117. Cancer Control. 2021. PMID: 34565216 Free PMC article.
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK, O'Sullivan B, Huang SH, Chau TC, Lam KO, Chan SY, Tong CC, Vardhanabhuti V, Kwong DL, Ng CY, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: choi hc. Cancers (Basel). 2022 Apr 11;14(8):1923. doi: 10.3390/cancers14081923. Cancers (Basel). 2022. PMID: 35454830 Free PMC article.
458 results